A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression [1]

Journal of Nuclear Medicine

Volumn 47, Issue 3, 2006, Pages 552-553

  Zöphel, Klaus ^a   Wunderlich, Gerd ^a   Kotzerke, Jörg ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROGLOBULIN AUTOANTIBODY; THYROTROPIN; TUMOR MARKER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

CANCER PATIENT; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIFFERENTIATED THYROID CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; IMMUNORADIOMETRIC ASSAY; LETTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; THYROID CANCER; THYROID CARCINOMA; WHOLE BODY SCINTISCANNING; BLOOD; CLINICAL TRIAL; DIAGNOSTIC ERROR; LABORATORY DIAGNOSIS; METHODOLOGY; NOTE; PRACTICE GUIDELINE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; THYROID TUMOR; TUMOR RECURRENCE; WHOLE BODY COUNTING;

CLINICAL TRIALS; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IODINE RADIOISOTOPES; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; WHOLE-BODY COUNTING;

EID: 33646003298     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (17)

1. 131I whole-body scanning. J Nucl Med. 2005;46:1473-1480.
2. Clark PM, Beckett G. Can we measure serum thyroglobulin? Ann Clin Biochem. 2002;39:196-202.
3. Black EG, Cassoni A, Gimlette TMD, et al. Serum thyroglobulin in thyroid cancer. Lancet. 1981;2:443-445.
4. Mazzaferri EL. Editorial: treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab. 1995;80:1485-1487.
5. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem. 1996;42:164-173.
6. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med. 1987;28:1888-1891.
7. Rubello D, Casara D, Girelli ME, Piccolo M, Busnardo B. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med. 1992;33:1478-1480.
8. Spencer CA, Takeuchi M, Kazarosyan C, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1998;83:1121-1127.
9. Spencer CA. Recoveries cannot be used to authenticate thyroglobulin (Tg): measurements when sera contain Tg autoantibodies. Clin Chem. 1996;42:661-663.
10. Zöphel K, Wunderlich G, Smith BR. Serum thyroglobulin measurements with a high-sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid. 2003;13:861-865.
11. Görges R, Brandt-Mainz K, Freudenberg L, Frilling A, Grimm W, Bockisch A. Kontinuierliche Sensitivitätssteigerung in der Schilddrüsenkarzinom-Nachsorge im Verlauf dreier Thyreoglobulin-IMA- Generationen. Nuklearmedizin. 2003;42:157-166.
12. Wunderlich G, Zöphel K, Crook L, Smith S, Smith BR, Franke WG. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin. Thyroid. 2001;11:819-824.
13. Zöphel K, Wunderlich G, Franke WG. Initial experiences with a highly sensitive enzyme-linked-immuno-sorbent assay (ELISA) for measurement of thyroglobulin in patients with differentiated thyroid carcinoma. J Lab Med. 2002;26:425-433.
14. Zöphel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG. Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma. Nuklearmedizin. 2001;40:155-163.
15. Beever K, Bradbury J, Phillips D, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem. 1989;35:1949-1954.
16. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, Lopresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab. 2005;90:5566-5575.
17. Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab. 2004;89:3702-3704.